Björn Torsteinsrud

Associate, Stockholm

Biography

Overview

Björn Torsteinsrud is an associate in our Capital Markets practice in Stockholm and joined White & Case in 2018. He advises clients on a wide variety of Capital Markets transactions and public M&A, including IPOs, PIPEs, rights issues and takeovers. His practice also includes advising listed companies on corporate governance matters.

Prior to joining White & Case, Björn studied at Stockholm University and at Humboldt University of Berlin and worked as a trainee at the Embassy of Sweden in Mexico City.

Education
LLM
Juris kandidat
Stockholm University
Studies in Commercial Law
Humboldt University of Berlin

Germany

Languages
Swedish
English
Spanish
German

Experience

Representative transactions include advising/representing:

FSN Capital Partners in connection with a sell-down of shares in listed company Bygghemma. The buyers were EQT Public Value Fund and various institutional investors and the total value of the shares sold amounted to approximately SEK 1.3 billion.

Karo Pharma in connection with its fully underwritten SEK 2.0 billion rights issue.

DNB, Danske Bank and Nordea as managers in connection with the SEK 1,215 million rights issue in Ambea AB, a company listed on Nasdaq Stockholm.

Carnegie and Nordea in connection with the SEK 4.2 billion IPO and Nasdaq Stockholm listing of Karnov Group.

Gaming Innovation Group, a company incorporated in Delaware and listed on the Oslo Stock Exchange, in connection with the dual listing of the company's shares on Nasdaq Stockholm.

ÅF on the recommended cash Tender Offer for all shares in Pöyry. ÅF and Pöyry have signed an agreement to combine the two companies to form a leading European engineering and consulting company.

European Entertainment Intressenter BidCo AB (EE Intressenter) on the public cash offer to the shareholders in Cherry AB to acquire all Cherry shares at a price of SEK 87 per share.

RBC Capital Markets, Cowen and Skandinaviska Enskilda Banken as placement agents in connection with the SEK680 million (equivalent to approximately US$75 million) placement of newly issued shares and existing shares in Hansa Medical, a company listed on Nasdaq Stockholm.

Nordea Bank and Skandinaviska Enskilda Banken as underwriters in connection with the SEK 1,650 million (equivalent to approximately US$183 million) rights issue in Mekonomen, a company listed on Nasdaq Stockholm.

Deutsche Bank and Nordea as the joint bookrunners and placement agents in connection with Hoist Finance's SEK 568 million equity capital raising.

EQT on the public cash offer to the shareholders of Karo Pharma.

Arion Banki, a leading universal relationship bank in Iceland, and Kaupthing in connection with the IPO and dual-listing in Stockholm and Reykjavik of Arion Bank.

Projektengagemang and its founders in connection with the IPO and Nasdaq Stockholm listing of Projektengagemang.

DNB, Swedbank and Crédit Agricole as placement agents in connection with the private placement of shares in Recipharm.